Why is Fredun Pharma falling/rising?

As of 18-Jul, Fredun Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs 912.00, which reflects a decrease of Rs 28.0 or 2.98%. The stock has underperformed its sector by 2.43% today and has been on a consecutive downward trend for the last three days, resulting in a total decline of 5.5% during this period. Despite this recent downturn, the stock has shown positive performance over the past week and month, with returns of 5.86% and 11.27%, respectively. Additionally, the company has demonstrated strong long-term growth, with net sales increasing at an annual rate of 32.11% and operating profit at 49.33%. However, the stock's recent performance is affected by falling investor participation, as evidenced by a significant drop in delivery volume.
In the broader market context, Fredun Pharmaceuticals has outperformed the Sensex over the past week and month, which saw the benchmark decline by 0.90% and increase by 0.38%, respectively. However, the stock's recent struggles may be attributed to its current liquidity issues and declining investor interest, as indicated by the substantial drop in delivery volume. While the company has reported positive financial results over the last four quarters and maintains an attractive valuation compared to its peers, the recent price movement suggests that short-term investor sentiment may be weighing heavily on the stock despite its strong fundamentals.